High-Dose Propranolol in Schizophrenia
- 1 May 1979
- journal article
- Published by Royal College of Psychiatrists in The British Journal of Psychiatry
- Vol. 134 (5) , 470-476
- https://doi.org/10.1192/bjp.134.5.470
Abstract
Summary: Eight male schizophrenics were treated in an open study with d.l. propranolol. The dose was increased by 160 mg/day until a maximum of 2,400 mg/day was achieved on day 15, and this remained constant until day 21. Seven patients showed significant clinical evidence of psychiatric improvement, while the incidence of toxic side-effects was low. There was wide inter-patient variation in plasma levels of propranolol. Despite a significant increase of plasma propranolol between day 15 and day 21 of the study, there was no significant change in serum prolactin.Keywords
This publication has 13 references indexed in Scilit:
- DECREASE IN SERUM-PROLACTIN AFTER PROPRANOLOL IN SCHIZOPHRENIAThe Lancet, 1978
- PROPRANOLOL AND PROLACTINThe Lancet, 1977
- PROPRANOLOL IN SCHIZOPHRENIAThe Lancet, 1977
- Effects of the isomeric forms of propranolol on central monoamine metabolism in regions of rat brainProgress in Neuro-Psychopharmacology, 1977
- (−)-Propranolol inhibits the behavioural responses of rats to increased 5-hydroxytryptamine in the central nervous systemNature, 1976
- The Effect of Neuroleptics on Serum Prolactin in Schizophrenic PatientsArchives of General Psychiatry, 1976
- Plasma propranolol levels in adults With observations in four childrenClinical Pharmacology & Therapeutics, 1970
- Propranolol uptake into the central nervous system and the effect on rat behaviour and amine metabolismJournal of Pharmacy and Pharmacology, 1968
- The nurses' observation scale for inpatient evaluation. A new scale for measuring improvement in chronic schizophreniaJournal of Clinical Psychology, 1965
- The Brief Psychiatric Rating ScalePsychological Reports, 1962